Categories for News
Additional contract win with Top 10 Pharma Company
September 2, 2024 10:22 am
US $1.5m Contract Win with Top 10 Pharma Company
August 9, 2024 6:01 am
Investor Update
May 22, 2024 3:37 pm
Oncimmune Announces Six Month Interim Results
May 21, 2024 9:27 am
Oncimmune Targets Age-Related Diseases with Biomarker Research.
April 23, 2024 9:33 am
Oncimmune provides update on recent trading, the outlook for 2024 and announces its 12-month period audited results.
February 29, 2024 10:56 am
Progress against strategy
November 30, 2023 9:41 amMartin Gouldstone, CEO updates investors on Oncimmune’s new strategy
October 26, 2023 9:21 pm